Enlight Biosciences highlights struggles for ‘precompetitive’ biotechs

Enlight Biosciences highlights struggles for ‘precompetitive’ biotechs

STAT Plus: Enlight Biosciences was going to ‘transform pharma R&D.’ What happened?

By KATE SHERIDAN

ADOBE

Enlight was supposed to “transform pharma R&D,” as one slide deck put it. But now, the three companies it spun out are either shuttered or struggling.

READ MORE